Bo Wah Enterprises Inc — FDA Warning Letter, 2026-08-13: Foreign Supplier Verification Program (FSVP)
Letter issued · posted to fda.gov .
Subject as published: Foreign Supplier Verification Program (FSVP)
TL;DR
Here's the summary: The FDA issued a warning letter to Bo Wah Enterprises Inc (Danny Y.W. Au, President) on August 13, 2026, following FSVP inspections on June 24, June 30, and July 1, 2026, citing failure to develop, maintain, and follow a Foreign Supplier Verification Program for imported foods including Huai Shan, Golden Mushroom, and Sesame Paste, and failure to verify that canned foods were produced in accordance with 21 CFR part 113 for thermally processed low-acid foods. The FDA stated the company's July 13, 2026 response lacked supporting documentation of corrective actions and requested a written response within 15 working days addressing specific violations and demonstrating compliance corrections, warning that failure to do so may result in refusal of admission, detention without physical examination, or other enforcement action.
Argus analysis
# FDA Warning Letter Analysis: Bo Wah Enterprises Inc
**Company and Findings**
Bo Wah Enterprises Inc, a Honolulu-based food importer led by President Danny Y.W. Au, received a warning letter from the FDA's Office of Inspections and Investigations on August 13, 2026, following a Foreign Supplier Verification Program (FSVP) inspection conducted June 24–July 1, 2026. The FDA determined the company failed to establish required verification procedures for imported foods, including Chinese yam, golden mushroom, and sesame paste. The inspection revealed systemic gaps in supplier verification documentation and control measures.
**Regulatory Citations and Meaning**
The violations centered on 21 CFR Part 1, Subpart L (the FSVP regulation) and Section 805 of the Federal Food, Drug, and Cosmetic Act. Specifically, the FDA cited 21 CFR 1.502(a), requiring importers to develop, maintain, and follow an FSVP tailored to their products. Bo Wah had no documented FSVP for any imported foods. Additionally, 21 CFR 1.502(b)(1) requires verification that low-acid canned foods comply with thermal processing standards under 21 CFR Part 113; the company provided no such documentation for canned products. These sections establish mandatory baseline protections ensuring imported food meets domestic safety standards before reaching consumers.
**Timeline and Compliance Watch Points**
Bo Wah has 15 working days from letter receipt to respond with corrective actions and supporting documentation. The company acknowledged receiving inspection observations on July 13 but submitted no substantive proof of compliance measures. Industry peers should monitor whether Bo Wah submits a credible FSVP with supplier audit records and thermal processing certifications. The FDA warned of potential detention without physical examination (DWPE) under Import Alert #99-41 and possible refusal of entry for non-compliant shipments. Failure to adequately remedy violations within the stated timeframe could trigger enforcement action under Section 301(zz) of the FD&C Act.
Severity context
Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
Regulatory background
FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER Bo Wah Enterprises Inc MARCS-CMS 736539 — August 13, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Express Delivery Product: Food & Beverages Recipient: Recipient Name Danny Y.W. Au Recipient Title President Bo Wah Enterprises Inc 1037 Maunakea St Honolulu , HI 96817-5130 United States (b)(6), (b)(7)(C) Issuing Office: Office of Inspections and Investigations United States August 13, 2026 WARNING LETTER Re: CMS 736539 Dear Mr. Au: On June 24, June 30, and July 1, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of BO WAH ENTERPRISES INC, 1037 Maunakea St, Honolulu, HI 96817-5130. This inspection was conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We acknowledge receipt of your response, dated July 13, 2026, in which you stated your firm (b)(4) develop your FSVP, requested HACCP and (b)(4) certificates from your foreign suppliers, and plans to send a firm member/employee to (b)(4) training. We are unable to evaluate the adequacy of your response because you have not provided any supporting documentation demonstrating your corrective actions. To date, no additional FSVP documents have been received by FDA. Your significant violations of the FSVP regulation are as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for any of the foods you import, including each of the following foods: (b)(4) Huai Shan (Chinese Yam), imported from (b)(4) located in (b)(4) (b)(4) Golden Mushroom, imported from (b)(4) located in (b)(4) (b)(4) Sesame Paste, imported from (b)(4) located in (b)(4) For thermally processed low-acid foods packaged in hermetically sealed containers (low-acid canned foods), with respect to those microbiological hazards that are controlled by following 21 CFR part 113, y…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- When did FDA issue the warning letter to Bo Wah Enterprises Inc?
- FDA issued the letter (MARCS-CMS 736539) on 2026-08-13 and posted it publicly on fda.gov on 2026-09-29.
- Is the FDA warning letter to Bo Wah Enterprises Inc publicly available?
- Yes. The full verbatim letter is published at fda.gov. Argus HQ links directly to the source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bo-wah-enterprises-inc-736539-08132026.
- What does a "low" severity rating mean for this letter?
- Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
- What is the regulatory background for a Warning Letter warning letter?
- FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Bo Wah Enterprises Inc — FDA Warning Letter, 2026-08-13: Foreign Supplier Verification Program (FSVP). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-bo-wah-enterprises-inc-2026-08-13-warning-letter
"Bo Wah Enterprises Inc — FDA Warning Letter, 2026-08-13: Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-bo-wah-enterprises-inc-2026-08-13-warning-letter.
Argus HQ Research. "Bo Wah Enterprises Inc — FDA Warning Letter, 2026-08-13: Foreign Supplier Verification Program (FSVP)." Digital Empire Holdings LLC. Accessed October 1, 2026. https://argushq.ai/fda/warning-letter/fda-wl-bo-wah-enterprises-inc-2026-08-13-warning-letter.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_bo_wah_enterprises_inc_2026_08_13_warning_letter_2026,
title = {Bo Wah Enterprises Inc — FDA Warning Letter, 2026-08-13: Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-bo-wah-enterprises-inc-2026-08-13-warning-letter},
note = {Accessed: October 1, 2026}
}